Lonza Viral Therapy Facility is a 276,770 biotechnology facility recently constructed in suburban Houston, Texas. The property is 100% leased to Lonza America, Inc., a wholly-owned subsidiary of Lonza Group AG, a leading Swiss biotechnology and pharmaceutical company. Strategically located in the City of Pearland, one of Houston’s fastest-growing suburbs, the Property is in close proximity to the Texas Medical Center, the world’s largest medical district, in addition to numerous life science and healthcare developments within the newly-formed Lower Kirby District. This state-of-the-art facility features a housing office space, a process development unit, quality control laboratories, and a fully segregated fill/finish suite. The facility also contains independent modular cleanrooms designed to manufacture cell therapy products.